Quick10K

⚲

LegacyTexas Financial

Filings

10-Q	2019-06-30	Filed 2019-07-24
10-Q	2019-03-31	Filed 2019-04-23
10-K	2018-12-31	Filed 2019-02-07
10-Q	2018-09-30	Filed 2018-10-24
10-Q	2018-06-30	Filed 2018-07-25
10-Q	2018-03-31	Filed 2018-04-25
10-K	2017-12-31	Filed 2018-02-08
10-Q	2017-09-30	Filed 2017-10-24
10-Q	2017-06-30	Filed 2017-07-25
10-Q	2017-03-31	Filed 2017-04-25
10-K	2016-12-31	Filed 2017-02-09
10-Q	2016-09-30	Filed 2016-10-25
10-Q	2016-06-30	Filed 2016-07-26
10-Q	2016-03-31	Filed 2016-04-25
10-K	2015-12-31	Filed 2016-02-26
10-Q	2015-09-30	Filed 2015-10-27
10-Q	2015-06-30	Filed 2015-07-29
10-Q	2015-03-31	Filed 2015-04-29
10-K	2014-12-31	Filed 2015-02-25
10-Q	2014-09-30	Filed 2014-10-28
10-Q	2014-06-30	Filed 2014-07-29
10-Q	2014-03-31	Filed 2014-04-29
10-K	2013-12-31	Filed 2014-02-26
10-Q	2013-09-30	Filed 2013-11-12
10-Q	2013-06-30	Filed 2013-07-30
10-Q	2013-03-31	Filed 2013-04-30
10-K	2012-12-31	Filed 2013-02-20
10-Q	2012-09-30	Filed 2012-10-30
10-Q	2012-06-30	Filed 2012-07-26
10-Q	2012-03-31	Filed 2012-04-27
10-K	2011-12-31	Filed 2012-02-28
10-Q	2011-09-30	Filed 2011-10-27
10-Q	2011-06-30	Filed 2011-07-28
10-Q	2011-03-31	Filed 2011-04-28
10-K	2010-12-31	Filed 2011-03-03
10-Q	2010-09-30	Filed 2010-11-04
10-Q	2010-06-30	Filed 2010-07-26

Reports

8-K	2019-10-31
8-K	2019-10-28
8-K	2019-10-23
8-K	2019-10-21
8-K	2019-10-11
8-K	2019-10-08
8-K	2019-07-24
8-K	2019-06-16
8-K	2019-06-16
8-K	2019-05-20
8-K	2019-05-17
8-K	2019-04-24
8-K	2019-04-23
8-K	2019-04-10
8-K	2019-03-01
8-K	2019-01-23
8-K	2019-01-22
8-K	2019-01-09
8-K	2018-12-10
8-K	2018-10-17
8-K	2018-10-16
8-K	2018-10-09
8-K	2018-07-18
8-K	2018-07-17
8-K	2018-07-05
8-K	2018-05-21
8-K	2018-05-18
8-K	2018-04-18
8-K	2018-04-17
8-K	2018-04-04
8-K	2018-03-01
8-K	2018-01-24
8-K	2018-01-23
8-K	2018-01-10

LegacyTexas Financial Financials

LTXB Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30
Cash	51	54	46	45	70	61	69	53	58	74	88	122	166	90	132	284	192	242	616	317	423	278	289	355	318	327	293	295	260	254	269	275	264
Accounts Receivable
Inventory
PP&E	48	49	50	50	54	53	97	53	53	53	99	53	52	51	86	82	80	79	113	71	71	72	110	72	71	70	109	70	71	72	115	108	106
Assets	2,964	3,235	3,181	3,041	3,693	3,636	3,663	3,374	3,594	3,384	3,525	3,604	3,951	3,951	4,164	6,513	6,670	6,879	7,692	7,562	8,057	8,440	8,362	8,437	8,970	9,069	9,086	8,866	9,249	9,083	9,051	9,346	9,936
Accounts Payable
Long-Term Debt																			1,614				1,061				1,268				1,016
Liabilities	2,557	2,829	2,774	2,629	3,187	3,120	3,142	2,843	3,061	2,844	2,981	3,053	3,394	3,386	3,596	5,751	5,893	6,086	6,888	6,739	7,214	7,573	7,477	7,537	8,045	8,119	8,126	7,886	8,248	8,043	7,957	8,225	8,793
Stockholders' Equity	407	407	406	413	506	516	521	531	533	540	544	550	557	564	568	761	777	793	804	823	843	867	885	900	925	950	960	979	1,001	1,040	1,094	1,121	1,143


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30
Revenue
Cost of Revenue
Gross Profit								8	8	8	7	8	9	9	5	16	20	18	16	22	23	27	25	18	28	29	15	26	28	43		29	27
R&D
SG&A
Tax	2	3	4	4	9	6	2	5	5	4	3	4	5	5	3	9	11	10	9	12	13	14	14	8	14	15	28	6	7	11		8	7
Net Income	5	5	10	7	8	11	10	8	8	8	7	8	9	9	5	16	20	18	16	22	23	27	25	18	28	29	15	26	28	43	58	29	27


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30
Cash Operating		-259	-138	112	-179	-69	-31	317	-124	292	-419	13	21	22	-5	11	44	34	1	56	19	63	-5	97	43	52	-3	48	54	86		79	19
Cash Investing		3	184	32	95	134	22	-40	-77	-42	293	-48	-306	-79	-173	-254	-266	-163	-449	-171	-383	-538	73	-25	-575	-88	-81	218	-436	150		-281	-577
Cash Financing		259	-54	-146	110	-75	17	-293	207	-234	140	69	329	-19	220	394	130	179	822	-183	469	331	-57	-6	495	45	50	-265	346	-241		208	547